The effect of transforming growth factor-beta on steroidogenesis and expression of key steroidogenic enzymes with a human ovarian thecal-like tumor cell model
- PMID: 8623837
- DOI: 10.1016/s0002-9378(96)70652-x
The effect of transforming growth factor-beta on steroidogenesis and expression of key steroidogenic enzymes with a human ovarian thecal-like tumor cell model
Abstract
Objective: Our purpose was to determine the effects of transforming growth factor-beta on steroidogenesis and regulation of steroidogenic enzyme expression by use of a human ovarian thecal-like tumor cell culture system.
Study design: Human ovarian thecal-like tumor cells were treated in serum-free medium in the presence or absence of forskolin and transforming growth factor-beta 1. The accumulation of progesterone and androstenedione in the culture medium was evaluated by radioimmunoassay. The effects of forskolin with or without transforming growth factor-beta 1 on the enzymatic activity of P450c17 and 3 beta HSD, the expression of immunodetectable P450c17 protein, and the expression of messenger ribonucleic acid for P450scc, P450c17, and 3 beta HSD were determined.
Results: Basal steroid secretion, steroidogenic enzyme activity, enzyme protein, and messenger ribonucleic acid expression were not affected by transforming growth factor-beta 1 alone. Forskolin treatment significantly stimulated steroid production and the enzymatic activity of P450c17 and 3 beta HSD up to 10-fold above basal levels. However, transforming growth factor-beta 1 inhibited forskolin-stimulated androstenedione production to near basal levels and increased progesterone 1.4- to 2-fold while suppressing P450c17 enzyme activity to near basal levels, but it did not affect 3 beta HSD activity. Forskolin-stimulated immunodetectable P450c17 alpha protein was markedly inhibited by transforming growth factor-beta 1. In addition, transforming growth factor-beta 1 markedly inhibited the forskolin-stimulation of P450c17 messenger ribonucleic acid, while not significantly altering P450scc or 3 beta HSD messenger ribonucleic acid expression.
Conclusion: Forskolin stimulated human ovarian thecal-like tumor cell steroidogenesis, P450c17 and 3 beta HSD activity, immunodetectable P450c17, and messenger ribonucleic acid content for P450scc, P450c17, and 3 beta HSD. Transforming growth factor-beta 1 inhibited forskolin stimulation of androstenedione production through the inhibition of P450c17 expression.
Similar articles
-
Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: a short tabular data collection.Ann N Y Acad Sci. 2002 Jun;966:166-86. doi: 10.1111/j.1749-6632.2002.tb04213.x. Ann N Y Acad Sci. 2002. PMID: 12114270 Review.
-
Bone morphogenetic protein inhibits ovarian androgen production.J Clin Endocrinol Metab. 2000 Sep;85(9):3331-7. doi: 10.1210/jcem.85.9.6835. J Clin Endocrinol Metab. 2000. PMID: 10999829 Clinical Trial.
-
Inhibin and activin differentially regulate androgen production and 17 alpha-hydroxylase expression in human ovarian thecal-like tumor cells.J Endocrinol. 1996 Feb;148(2):213-21. doi: 10.1677/joe.0.1480213. J Endocrinol. 1996. PMID: 8699135
-
The effect of insulin and insulin-like growth factors on the expression of steroidogenic enzymes in a human ovarian thecal-like tumor cell model.Fertil Steril. 1996 Jan;65(1):87-93. doi: 10.1016/s0015-0282(16)58032-7. Fertil Steril. 1996. PMID: 8557160
-
The role of transcriptional regulation in steroid hormone biosynthesis.J Steroid Biochem Mol Biol. 1991;40(4-6):517-25. doi: 10.1016/0960-0760(91)90271-6. J Steroid Biochem Mol Biol. 1991. PMID: 1659886 Review.
Cited by
-
Tiaogeng Yijing decoction improves the pregnancy outcomes of patients with poor ovarian response undergoing in vitro fertilization-embryo transfer.Exp Ther Med. 2017 Oct;14(4):3935-3941. doi: 10.3892/etm.2017.4948. Epub 2017 Aug 16. Exp Ther Med. 2017. PMID: 29043003 Free PMC article.
-
Multiple signal transduction pathways regulate ovarian steroidogenesis.Rev Endocr Metab Disord. 2002 Jan;3(1):33-46. doi: 10.1023/a:1012748718150. Rev Endocr Metab Disord. 2002. PMID: 11883103 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical